{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:09:15Z","timestamp":1775876955870,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University of Washington School of Medicine Medical Student Research Training Program"},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.drugalcdep.2017.09.017","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:47:11Z","timestamp":1507834031000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Linking patients with buprenorphine treatment in primary care: Predictors of engagement"],"prefix":"10.1016","volume":"181","author":[{"given":"Claire B.","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph O.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Addy","family":"Adwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Tamru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared W.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: outcomes at year 7","volume":"12","author":"Bhatraju","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0010","first-page":"282","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"1","author":"Brooklyn","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0015","series-title":"Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings","author":"Chou","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","article-title":"Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study","volume":"94","author":"Clausen","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2016.06.003","article-title":"Buprenorphine initiation and linkage to outpatient buprenorphine do not reduce frequency of injection opiate use following hospitalization","volume":"68","author":"Cushman","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0030","first-page":"1636","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"A Random. Clin. Trial JAMA"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0035","first-page":"1273","article-title":"The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-Based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the massachusetts collaborative care model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ajad.12414","article-title":"Predictors of early dropout in outpatient buprenorphine\/naloxone treatment","volume":"25","author":"Marcovitz","year":"2016","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0060","series-title":"Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence. Cochrane Database Syst. Rev. CD002207","author":"Mattick","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0065","series-title":"Number and Age-adjusted Rates of Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999\u20132014. CDC","author":"National Center for Health Statistics National Vital Statistics System","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/00952990701523698","article-title":"Quality of life among heroin users on buprenorphine versus methadone maintenance","volume":"33","author":"Ponizovsky","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0075","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004\u20132013","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0080","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/add.13479","article-title":"Adopting the \u2018cascade of care' framework: an opportunity to close the implementation gap in addiction care?","volume":"111","author":"Soc\u00edas","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0090","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0095","series-title":"Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. D.o.h.a.h. Services TIP 43","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0100","series-title":"Behavioral Health Trends in the United States:Results from the 2014 National Survey on Drug Use and Health Center for Behavioral Health Statistics and Quality","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.09.017_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:55:21Z","timestamp":1759827321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617304994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":22,"alternative-id":["S0376871617304994"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.017","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking patients with buprenorphine treatment in primary care: Predictors of engagement","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}